MajorJohnny you incorrectly paraphrase me as stating the CDY report is disappointing...it is not and very far from it.
I have very high regard of both Co's Management and their underlying strategy and execution. I am keen, as I've stated many times some more information on the Mk portfolio would be good however i recognise the secrecy needed in this competitive Biotech space.
I have little interest in the current SP as it is not relevant to my strategy at this stage. ie I am accumulating both.
If you think the CEO should be removed then you can have this raised as an agenda item at the AGM/GM and I look forward to meeting you there.
No I am not "Deep" in the red..just a little atm and green with SEN (just).
The Board are growing the company and similarly would like to see a much greater SP however there mandate is not to pump the SP rather develop the company which they are doing admirably imo. If you disagree then good for you.